An Intelligent Transdermal Formulation of ALA‐Loaded Copolymer Thermogel with Spontaneous Asymmetry by Using Temperature‐Induced Sol–Gel Transition and Gel–Sol (Suspension) Transition on Different Sides
Source abstract
Abstract
Abstract Aqueous solutions of some amphiphilic block copolymers undergo a sol–gel transition upon heating and are thus called thermogels. In the thermogel family, some systems also exhibit a gel–sol (suspension) transition at higher temperatures following the sol–gel transition, which is usually ignored in biomedical applications. Herein, for the first time, a case is reported employing both the sol–gel transition and the gel–sol (suspension) transition, which is found in the development of a transdermal hydrogel formulation containing 5‐aminolevulinic acid for photodynamic therapy (PDT) of skin disease. Two poly(d,l‐lactide‐co‐glycolide)‐b‐poly(ethylene glycol)‐b‐poly(d,l‐lactide‐co‐glycolide) triblock copolymers of different block lengths are synthesized. The transition temperatures of the formulation can be easily adjusted to meet the condition of sol–gel transition temperature (Tgel) < room temperature (Tair) < gel–sol (suspension) temperature (Tsol (suspension)) < body temperature (Tbody) via changing the blending ratio. Therefore, after applying to skin, formulation of spontaneous asymmetry with a hydrogel outside and a sol (suspension) inside can avoid free flowing and achieve rapid release to ensure an efficient PDT. This study demonstrates such a concept via characterizations of the “block blend” biomaterials and drug release profiles, and also via cell experiments, in vitro permeation, and in vivo transdermal delivery studies.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Hydrogels: synthesis, properties, applications · Photodynamic Therapy Research Studies · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Molecular Engineering of Polymers Department of Macromolecular Science Fudan University Shanghai 200438 China
Shanghai Fudan‐Zhangjiang Bio‐Pharmaceutical Co., Ltd. Shanghai 201210 China
Zhuhai Fudan Innovation Institute Zhuhai Guangdong 519000 China
References (96)
Show source-provided references
1. 10.1038/373049a010.1038/373049a0 ↗
2. 10.1016/j.jconrel.2014.06.03510.1016/j.jconrel.2014.06.035 ↗
3. 10.1016/j.jconrel.2017.08.00610.1016/j.jconrel.2017.08.006 ↗
4. 10.1186/s40824-020-00200-810.1186/s40824-020-00200-8 ↗
5. 10.1016/S0169-409X(01)00242-310.1016/S0169-409X(01)00242-3 ↗
6. 10.1016/j.jconrel.2008.01.00510.1016/j.jconrel.2008.01.005 ↗
7. 10.1016/j.jconrel.2018.07.00910.1016/j.jconrel.2018.07.009 ↗
8. 10.1016/j.actbio.2018.05.03910.1016/j.actbio.2018.05.039 ↗
9. 10.1039/D0NR03147J10.1039/D0NR03147J ↗
10. Zhao C. C. · Regener. Biomater. · 2020 · 7 · 99
11. 10.1016/j.biomaterials.2018.01.00110.1016/j.biomaterials.2018.01.001 ↗
12. 10.1093/rb/rbz01310.1093/rb/rbz013 ↗
13. 10.1002/adhm.20200125610.1002/adhm.202001256 ↗
14. 10.1016/j.jconrel.2011.07.00810.1016/j.jconrel.2011.07.008 ↗
15. 10.1016/j.biomaterials.2013.05.00510.1016/j.biomaterials.2013.05.005 ↗
16. Du B. B. · Macromol. Chem. Phys. · 2019 · 220 · 9
17. 10.1016/j.jconrel.2020.07.03110.1016/j.jconrel.2020.07.031 ↗
18. 10.1002/adfm.20200440710.1002/adfm.202004407 ↗
19. 10.1016/j.jconrel.2020.12.00810.1016/j.jconrel.2020.12.008 ↗
20. 10.1002/adfm.20180670810.1002/adfm.201806708 ↗
21. Hu D. R. · Adv. Funct. Mater. · 2019 · 29 · 14
22. 10.1002/adhm.20190089610.1002/adhm.201900896 ↗
23. 10.1186/s40824-019-0177-710.1186/s40824-019-0177-7 ↗
24. 10.1016/j.addr.2003.09.00210.1016/j.addr.2003.09.002 ↗
25. 10.1016/j.pdpdt.2011.09.00110.1016/j.pdpdt.2011.09.001 ↗
26. 10.1562/2006-02-03-IR-79410.1562/2006-02-03-IR-794 ↗
27. 10.1159/00001800610.1159/000018006 ↗
28. Lee P. K. · J. Drugs Dermatol. · 2013 · 12 · 925
29. 10.1023/A:100761290537810.1023/A:1007612905378 ↗
30. 10.1111/j.1751-1097.1999.tb05307.x10.1111/j.1751-1097.1999.tb05307.x ↗
31. 10.1016/j.jconrel.2009.01.00210.1016/j.jconrel.2009.01.002 ↗
32. 10.1111/j.1600-0625.2008.00705.x10.1111/j.1600-0625.2008.00705.x ↗
33. 10.1016/j.jconrel.2004.12.00510.1016/j.jconrel.2004.12.005 ↗
34. 10.1016/j.ejps.2005.10.00910.1016/j.ejps.2005.10.009 ↗
35. 10.1002/adfm.20120086410.1002/adfm.201200864 ↗
36. 10.1111/php.1220910.1111/php.12209 ↗
37. 10.1016/j.jconrel.2016.08.01510.1016/j.jconrel.2016.08.015 ↗
38. 10.1016/j.jconrel.2018.07.03810.1016/j.jconrel.2018.07.038 ↗
39. 10.1111/j.1365-2133.2011.10613.x10.1111/j.1365-2133.2011.10613.x ↗
40. 10.1007/s13204-013-0268-z10.1007/s13204-013-0268-z ↗
41. 10.1006/phrs.2001.093410.1006/phrs.2001.0934 ↗
42. 10.1002/jps.2115710.1002/jps.21157 ↗
43. 10.1021/acsami.5b1149310.1021/acsami.5b11493 ↗
44. 10.1080/09546630231741466310.1080/095466302317414663 ↗
45. 10.1111/bjd.1342010.1111/bjd.13420 ↗
46. 10.1517/17425247.5.7.75710.1517/17425247.5.7.757 ↗
47. 10.1038/4221810.1038/42218 ↗
48. 10.1016/j.ijpharm.2008.01.05710.1016/j.ijpharm.2008.01.057 ↗
49. 10.1016/j.biomaterials.2008.02.01610.1016/j.biomaterials.2008.02.016 ↗
50. 10.1039/b713009k10.1039/b713009k ↗
51. 10.1039/c2cs35078e10.1039/c2cs35078e ↗
52. 10.1016/j.actbio.2012.07.02110.1016/j.actbio.2012.07.021 ↗
53. 10.3390/polym610267010.3390/polym6102670 ↗
54. 10.1021/acsami.5b0911210.1021/acsami.5b09112 ↗
55. 10.1038/s41598-016-0008-110.1038/s41598-016-0008-1 ↗
56. 10.1002/smtd.20200031010.1002/smtd.202000310 ↗
57. 10.1002/adhm.20190031210.1002/adhm.201900312 ↗
58. 10.1002/1521-3927(20010501)22:8<587::AID-MARC587>3.0.CO;2-810.1002/1521-3927(20010501)22:8<587::AID-MARC587>3.0.CO;2-8 ↗
59. Cui S. Q. · Acta Polym. Sin. · 2018 · 8 · 997
60. 10.1002/adfm.20200039110.1002/adfm.202000391 ↗
61. 10.1038/pj.2014.3010.1038/pj.2014.30 ↗
62. 10.1016/j.biomaterials.2011.03.04610.1016/j.biomaterials.2011.03.046 ↗
63. 10.1021/bm400804w10.1021/bm400804w ↗
64. 10.1021/ma990899910.1021/ma9908999 ↗
65. 10.1021/ma702648410.1021/ma7026484 ↗
66. 10.1021/acs.macromol.5b0016810.1021/acs.macromol.5b00168 ↗
67. 10.1021/acs.macromol.8b0101410.1021/acs.macromol.8b01014 ↗
68. 10.1002/anie.20050357510.1002/anie.200503575 ↗
69. 10.1002/pola.2187610.1002/pola.21876 ↗
70. 10.1021/acs.macromol.0c0143010.1021/acs.macromol.0c01430 ↗
71. 10.1016/S0168-3659(01)00276-010.1016/S0168-3659(01)00276-0 ↗
72. 10.1021/cr200157d10.1021/cr200157d ↗
73. 10.1016/j.biomaterials.2013.01.01310.1016/j.biomaterials.2013.01.013 ↗
74. 10.1093/rb/rbz02210.1093/rb/rbz022 ↗
75. 10.1038/srep0547310.1038/srep05473 ↗
76. 10.1016/j.ejps.2014.06.00210.1016/j.ejps.2014.06.002 ↗
77. 10.1016/j.ijpharm.2010.03.03310.1016/j.ijpharm.2010.03.033 ↗
78. 10.1021/acsami.6b0941510.1021/acsami.6b09415 ↗
79. 10.1016/j.biomaterials.2010.03.02710.1016/j.biomaterials.2010.03.027 ↗
80. 10.3109/0363904100368082610.3109/03639041003680826 ↗
81. Xu W. K. · Chin. J. Polym. Sci. · 2019 · 37 · 543
82. 10.1021/acs.macromol.0c0248810.1021/acs.macromol.0c02488 ↗
83. Zhang Z. · Int. J. Clin. Exp. Med. · 2015 · 8 · 6517
84. 10.1016/j.jconrel.2005.07.00610.1016/j.jconrel.2005.07.006 ↗
85. 10.1016/j.cej.2020.12532010.1016/j.cej.2020.125320 ↗
86. 10.1111/j.1600-0625.2009.01001.x10.1111/j.1600-0625.2009.01001.x ↗
87. 10.1111/php.1250310.1111/php.12503 ↗
88. 10.1016/S1011-1344(01)00267-610.1016/S1011-1344(01)00267-6 ↗
89. 10.1016/S1011-1344(02)00278-610.1016/S1011-1344(02)00278-6 ↗
90. 10.1002/1520-6017(200010)89:10<1335::AID-JPS11>3.0.CO;2-#10.1002/1520-6017(200010)89:10<1335::AID-JPS11>3.0.CO;2-# ↗
91. 10.1016/S0928-0987(98)00009-810.1016/S0928-0987(98)00009-8 ↗
92. 10.1021/acsami.8b1749810.1021/acsami.8b17498 ↗
93. 10.1016/j.jconrel.2004.08.02510.1016/j.jconrel.2004.08.025 ↗
94. 10.1039/D0NR03494K10.1039/D0NR03494K ↗
95. 10.1021/acs.macromol.9b0053410.1021/acs.macromol.9b00534 ↗
96. 10.1021/acs.jchemed.0c0032510.1021/acs.jchemed.0c00325 ↗